Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

82P - Novel analysis of F. nucleatum subspecies in human CRC tissue and engineering of therapeutic F. nucleatum phage

Date

09 Dec 2020

Session

e-Poster Display Session

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Lihi Ninio-Many

Citation

Annals of Oncology (2020) 31 (suppl_7): S1441-S1451. 10.1016/annonc/annonc392

Authors

L. Ninio-Many, N. Buchshtab, I. Vainberg Slutskin, I. Weiner, S. Yahav

Author affiliations

  • BiomX LTD, Ness Ziona/IL
More

Abstract 82P

Background

Fusobacterium nucleatum (F. nucleatum) species was shown to be enriched in human CRC (Ito et al., 2015) and to correlate with poor prognosis (Yu et al., 2016). Bacteriophage (‘phage’) are viruses that specifically infect bacteria and play a critical role in regulating bacterial populations. We previously showed the isolation of 12 novel natural phages targeting all 4 sub-species of F. nucleatum: animalis, nucleatum, vincentii, polymorphum (Zelcbuch et al., AACR, 2020). The aims of the current study were to develop (1) Novel technologies and algorithms for differentiating between F. nucleatum subspecies while analyzing their abundance and prevalence in CRC samples (2) Synthetic biology tools for introducing therapeutic payloads into the F. nucleatum phage genome.

Methods

For F. nucleatum subspecies analysis, 59 pairs of frozen CRC tumor and normal adjacent tissues were subjected to species specific qPCR for calculating the absolute number of F. nucleatum cells. Targeted NGS of the NusG gene, was carried out to analyze the relative abundance of F. nucleatum subspecies. For phage engineering, plasmids containing payloads for immuno-stimulation treatment, such as IL15 and GM-CSF, were constructed and introduced into E.coli for payload bioactivity verification.

Results

Targeted-NGS revealed that F. nucleatum animalis was the most prevalent subspecies in the tested cohort (40/57 [70.1%]) and was significantly expressed in tumors compared to adjacent tissues (p= 7.3 E-03). The prevalence of other subspecies was lower: polymorphum (23/59 [39.8%]); vincentii or nucleatum– (11/59 [18.6%]). Payloads bioactivities were validated in E.coli: IL-15 induced significant bioluminescence expression in a reporter -based assay and a high proliferation rate in primary murine NK cells, GM-CSF induced a high proliferation rate of FDC-1-P1 cell line. Next steps include inserting the payloads into the phage genome and validating their functionality in animal models.

Conclusions

The high prevalence and abundance of the F. nucleatum animalis in CRC samples suggests it may serve as a target for phage-based treatment. Delivery of an immune-stimulating payload to CRC by engineered phage may offer novel treatment approaches for CRC patients.

Legal entity responsible for the study

BiomX LTD.

Funding

BiomX LTD.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.